Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07204704 · ClinicalTrials.gov registry record · NA
EUREKA: Evaluating Ultraviolet Radiation Exposure in Kids for Adaptive Intervention
A NA study of Skin Cancer, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT07204704: Completed NA study of Skin Cancer, sponsored by University of Utah.
NCT07204704 is a NA study of Skin Cancer that has completed, run by University of Utah. The registered enrollment target is 78 participants, below the 462-participant average among 40 other Skin Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07204704, a NA study of Skin Cancer, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will pilot a Just In Time Adaptive Intervention (JITAI) approach to providing feedback on child UVR exposure to children and their parents, with the ultimate goal of improving child use of sun protection strategies (e.g., use of sunscreen, protective clothing) and decreasing UVR exposure and sunburn occurrence. This study will utilize a SmartPhone app. If participants do not have a smartphone, they will be provided with one to use the app.
Primary Outcome
This outcome measure will report the frequency of self-report child sun protection using items that separately assess specific sun protection behaviors (e.g., sunscreen use).
Conditions Studied
Interventions
- BEHAVIORAL EUREKA Intervention
Study Locations (1)
Utah
- University of Utah Department of Dermatology - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-09-11 |
| Phase | NA |
What the finished NCT07204704 record still lists
NCT07204704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 462-participant average among 40 other Skin Cancer trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which EUREKA Intervention is the first listed.
NCT07204704 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07204704 about?
NCT07204704 is a clinical study titled "EUREKA: Evaluating Ultraviolet Radiation Exposure in Kids for Adaptive Intervention". This project will pilot a Just In Time Adaptive Intervention (JITAI) approach to providing feedback on child UVR exposure to children and their parents, with the ultimate goal of improving child use of sun protection strategies (e.g., use of sunscreen, protective clothing) and decreasing UVR exposur...
What is the current status of trial NCT07204704?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2024-07-01. Estimated completion is 2025-09-11.
What conditions does trial NCT07204704 study?
This clinical trial studies the following conditions: Skin Cancer.
What interventions are being tested in trial NCT07204704?
The interventions under investigation include: EUREKA Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07204704?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07204704 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07204704's enrollment target sits among peer trials
78 20th of 40 higher than 21 of 40 other Skin Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rural Adult and Youth Sun Protection Study
RECRUITING · NA
-
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
RECRUITING · NA
-
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
RECRUITING · NA
-
DNA Repair Activity in the Skin of Day and Night Shift Workers
RECRUITING · NA
-
Adaptive Symptom Self-Management Immunotherapy Study
RECRUITING · NA
-
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI